Summary The frequency and severity of fatty infiltration of the liver in patients receiving 5-fluorouracil (5-FU) and folinic acid has not been documented systematically. Its development can result in difficulty assessing disease progression, and treatment may be altered inappropriately. Twenty-seven patients with colon cancer and liver metastases receiving 5-FU and folinic acid were studied with computerized tomography (CT) before treatment and after six or 12 cycles of chemotherapy. Forty-seven per cent of patients developed hepatic steatosis during treatment. There was no correlation between development of hepatic steatosis and the dose of chemotherapy or the liver function tests. Hepatic steatosis occurs commonly in patients receiving 5-FU and folinic acid and can be severe. Its development can make hepatic metastases difficult to assess and if its benign nature is not appreciated treatment may be inappropriately altered.Keywords: colon cancer; liver steatosis; computerized tomography; chemotherapy; 5-fluorouracilIn the treatment of patients with advanced colorectal cancer, abdominal computerized tomography (CT) is the most widely used technique to determine stage and to monitor the response of liver metastases and other sites of disease to 5-fluorouracil (5-FU)-based chemotherapy. The diagnosis of metastatic disease is either made during laparotomy or by CT-or ultrasound-guided liver biopsy.It has been observed, while scanning such patients, that they may develop a decrease in liver attenuation consistent with steatosis during treatment with 5-FU, which is used extensively alone or in combination with other drugs for adenocarcinoma of the large bowel. Although fatty change of the liver is well recognized after administration of various chemotherapy regimens (Leevy and Tygstrup, 1976), its frequency and severity has not been documented. Also its occurrence after 5-FU alone or with folinic acid has been noted incidentally in one study and found only to occur when administered with interferon in another (Moertel et al, 1993;Sorensen et al, 1995). The accuracy of CT in establishing the presence of fatty change of the liver is well established (Bydder et al, 1980). The decrease in liver attenuation is important because metastases demonstrated on CT are usually of lower attenuation than normal liver parenchyma and as the liver becomes more fatty, and therefore less dense, the metastases can become increasingly difficult to delineate. This may result in the false impression of a therapeutic response. The confusion can be exacerbated particularly in the presence of focal sparring within fatty change that can mimic metastases (Yates and Streight, 1986). Treatment may be stopped if this benign cause for the liver appearances is misinterpreted as progressive disease.Received 11 August 1997 Revised 24 September 1997 Accepted 11 November 1997 Correspondence to: PD Peppercorn The aim of this study is to examine the frequency and severity of fatty change of the liver as seen on CT in patients receiving 5-FU and folinic...

Demonstration of accurate measurement of the depth of extramural tumor spread in the MERCURY Study enabled accurate preoperative prognostication.

Neuroendocrine tumours of the pancreas are rare and are frequently difficult to demonstrate. Several imaging modalities have been used to demonstrate these tumours, but recent reports have suggested that MRI may have an important role in their localization. We review the spectrum of MRI appearances of pancreatic neuroendocrine tumours.

The aim of this study was to determine the effect of reducing mAs on the diagnostic quality of images and the radiation dose to the orbits in patients undergoing sinus CT. We studied 40 consecutive patients undergoing paranasal sinus CT for inflammatory disease prior to functional endoscopic sinus surgery (FESS). Four groups of 10 patients were scanned at 200 mAs, 150 mAs, 100 mAs and 50 mAs, respectively. Orbital radiation dose was measured using thermoluminescent dosemeters. Images were reviewed independently by two observers who were unaware of the mAs setting used. Image quality was evaluated using a semi-quantitative scoring system for six anatomical structures. The osteomeatal complex, uncinate process, infundibulum, frontal recess, middle turbinate and optic nerve were assessed as: clearly demonstrated (2 points); demonstrated but not clearly visualized (1 point); or not seen (0 points). No significant difference was shown between any of the four groups in terms of image quality according to the scoring system used in this study. Mean radiation dose to the orbit was reduced by 77%, from 13.5 mGy at 200 mAs to 3.1 mGy at 50 mAs (p<0.05). CT of the sinuses can be performed in patients prior to FESS at greatly reduced mAs without loss of diagnostic quality of the images. This is important in reducing the radiation dose to the lens.

This is a small study, but MR imaging appears accurate in the prediction of myometrial tumor involvement and in showing the relationship of cervical carcinoma to the internal os and, hence, the patient's suitability for trachelectomy.